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PHARMACEUTICAL POLICY AS A RIGHT 
AND AS A SERVICE: REFLECTIONS ON 
POPULATION TRUST.
Silvana Nair Leite & Michael Calnan
In July 2018, during a visit to Canterbury Cathedral (England), we were surprised by the call of the 
parish priest for all the visitors to join a celebration. Imagining being a religious theme, what’s was surprising 
to hear “Today, July 5, the National Health Service (NHS) turns 70. This is a special date for our people and 
an opportunity to celebrate one of the nation’s most important institutions. We invite everyone to pray and 
thank the vital role played by the NHS in our lives, and to acknowledge and thank the outstanding NHS 
professionals - the role of doctors, nurses, pharmacists - who are there to guide us, provide support and care 
on day by day...”. Thus it is clear that the NHS for the English is both a popular institution and a sacred one.
Immediately, this situation led us to the reflect on trust as a fundamental element in the health area. 
All that week we had been at the University of Kent working on projects involving this concept. Calnan has 
been exploring  the theme Trust in Health Care for a number of years. Trust is a multilayered concept: it has 
a “cognitive element (based on rational and instrumental judgments) and an affective dimension (based on 
affective relationships and bonds) generated by interaction, empathy and identification with others.” Trust 
has been characterized by a part in which those who trust have positive expectations about the competence, 
knowledge and skills of the other party (the professional or an institution) to do a good job and be able to 
engage their best interests and with charity, impartiality and justice. (Calnan and Rowe, 2008). Trust is a 
common way of bridging uncertainty which is particularly important in the context of healthcare which is 
believed to be characterised by unpredictability and uncertainty leaving patients vulnerable and reliant on 
professional expertise (Brown and Calnan 2012). From the patient’s point of view trust is very much used 
as a marker of quality of care and can influence consultation behavior, disclosure and communication of 
information and adherence to clinical advice and treatment (Calnan and Rowe, 2008)
Blind trust or assumed trust has been superseded by conditional trust which is similar to the notion 
of acquired trust or a more reflective form of trust suggested by Giddens (1990), who is seen as a product 
of high or late modernity. For Gilson (2003), having a reliable health system that has the trust of society 
contributes to fostering its social value and social order. Public trust in the health system as an institution can 
also influence the extent to which the health system is seen as legitimate and can also influences acceptance 
and participation in it. Specific organizational benefits that can derive from trust as a form of social capital 
include reduced costs and increased efficiency (Calnan and Rowe,2008)
To establish the legitimacy of State action, it is necessary to build trust in the State and its institutions, 
recognizing that trust can not be taken for granted, but must be actively produced and negotiated (Giddens, 
1990).
In the same period, we were organizing a series of Regional Preparatory Meetings for the 8th 
National Symposium on Science, Technology and Pharmaceutical Policy and for the 16th National 
Conference of Health, in a partnership between the National School of Pharmacists, FIOCRUZ and the 
National Health Council. The challenge was, precisely, to mobilize society for the debate of public policies, 
particularly the National Pharmaceutical Policy1. And the question has arisen: does society rely on the 
pharmaceutical services it receives?
Recently, the National Survey on Access and Rational Use of Medicines (PNAUM) has shown, 
in numbers, important advances in access to medicines in Brazil. According to the study, 94.3% of Brazilians 
with some of the chronic diseases surveyed by PNAUM, and who had a prescription for medication to control 
the disease, had access to and used the prescribed medication. Of the Brazilians with chronic diseases, 47.5% 
obtained all the medicines they needed for free. When only hypertensive patients were analyzed, 72.0% of 
them received the medicines in SUS or Popular Pharmacy, and only 25.7% of hypertensive Brazilians paid for 
the drug (Bermudez; Barros 2016).
These results  corroborate the evidence from the  Participatory Evaluation of the 10 Years of the 
National Pharmaceutical Policy which  found in 2014 that  the perception of health professionals and patients 
was that access to medicines and pharmaceutical services in Brazil have increased significantly. Legal and 
2Rev. Bras. Farm. Hosp. Serv. Saúde 2018; 9(3):e093.001 
normative frameworks were consolidated, giving structure to develop pharmaceutical services in the context of the health policy. However, there are 
also perceptions of barriers to access to medicines (mainly in the north and northeast regions) and deficiencies in the management of pharmaceutical 
care, especially at the municipal level. Concerns about the political and economic sustainability of public policies were also highlighted in the evaluation 
(Faraco et al, 2017).
Reviewing evidence  from studies published in the last years of the Research Group on Pharmaceutical Policies and Services of UFSC on 
trajectories and experiences of patients in access to high-priced drugs (via the Specialized Component of Pharmaceutical Assistance or through the 
litigation process), and reconsidering them now in the perspective of trust in the health system, we can find a cruel picture of pilgrimages, humiliation, 
anguishes, and the understanding that in certain circumstances, access to medicines is a favor, not a right (Leite, Mafra 2010). In others, there is the 
perception that “they [the government) put difficult procedures, so that the person gives up and does not continue” (Carvalho, Leite 2014), that drugs 
are not lacking, but that there is too much bureaucracy preventing access to medicines (Rover et al 2016a ; 2016b).
We are experiencing in Brazil at the same time, the great development of pharmaceutical services, both in public and private institutions. 
For some of these services, there is already scientific evidence of positive health outcomes and patients satisfaction. Undoubtedly, this is an important 
move for the population to have a reference to the greater development of trust in the pharmaceutical professional and in the institutions (health units, 
pharmacies) as legitimate health services of greater social value. However, there seems to be a hyper-estimation of the capacity to obtain impactful and 
sustainable health outcomes from specific and isolated pharmaceutical services (not integrated in health care process). The risk we face in this case is that 
we have a negative impact on people’s conditional trust in pharmaceutical services and professionals.
In any case, the legitimacy and valuation of pharmaceutical policy as a right of people and a legitimate social good is defined by access to 
pharmaceutical products and services as a continuous whole. This complete access configuration is capable of developing for people the assurance that 
they will have appropriate treatment for their health problems and that they can rely on this health sector - both in the quality and effectiveness of the 
products and in the ability to obtain them and also the services that will be offered with the medicines.
We are living, therefore, a period of great relevance for our sector. In 2019 we will hold the 16th National Health Conference - and the 
municipal stages and thematic meetings are already beginning to take shape. The results of the Preparatory Meetings and the 8th National Symposium 
on Science, Technology and Pharmaceutical Policy (held in December 2018 at FIOCRUZ’s headquarters in Manguinhos) are already available through 
the Rio de Janeiro Charter (FIOCRUZ, 2018 and should guide our participation in the stages of the Conference, leading the debate on pharmaceutical 
policy and practices and the role of pharmacists and pharmacies to society as a whole. It is time for us to engage in the defense of the right of people to 
pharmacy - from product to services, and build? the relationship of trust with Brazilian society.
Silvana Nair Leite is pharmacist, Doctor in Public Health, professor at Universidade Federal de Santa Catarina and head of Federação 
Nacional de Farmacêuticos  e da Federação Nacional dos Farmacêuticos (FENAFAR). Michael Calnan is sociologist, professor at School of Social 
Policy, Sociology and Social Research from Universidade of Kent.
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